Literature DB >> 22049542

Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them.

M Cecilia Lansang1, Leighanne Kramer Hustak.   

Abstract

Glucocorticoids, commonly used to treat multiple inflammatory processes, can cause hyperglycemia, Cushing syndrome, adrenal suppression, and, when they are discontinued, adrenal insufficiency. Physicians must be aware of these adverse effects and be equipped to manage them.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22049542     DOI： 10.3949/ccjm.78a.10180

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  31 in total

Review 1.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

2.  The effect of steroid pulse therapy on carbohydrate metabolism in multiple myeloma patients: a randomized crossover observational clinical study.

Authors:  O Véber; A Wilde; J Demeter; G Tamás; I Mucsi; A G Tabák
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 3.  Hyperglycemia in patients with hematologic malignancies.

Authors:  Sara J Healy; Kathleen M Dungan
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

5.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

6.  Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.

Authors:  George Man; Theodora M Mauro; Peggy L Kim; Melanie Hupe; Yongjiao Zhai; Richard Sun; Debbie Crumrine; Carolyn Cheung; Almudena Nuno-Gonzalez; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2014-07-31       Impact factor: 3.960

Review 7.  Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function.

Authors:  Philip C Johnston; M Cecilia Lansang; Soumya Chatterjee; Laurence Kennedy
Journal:  Endocrine       Date:  2014-09-03       Impact factor: 3.633

8.  11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.

Authors:  Ying Wang; Chaoying Yan; Limei Liu; Wei Wang; Hanze Du; Winnie Fan; Kabirullah Lutfy; Meisheng Jiang; Theodore C Friedman; Yanjun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-11-11       Impact factor: 4.310

9.  Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study.

Authors:  D Harris; A Barts; J Connors; M Dahl; T Elliott; J Kong; T Keane; D Thompson; S Stafford; E Ur; S Sirrs
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

10.  Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia.

Authors:  Christian Rohrmeier; Nikola Koemm; Philipp Babilas; Philipp Prahs; Juergen Strutz; Roland Buettner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-28       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.